Diclofenac, a common painkiller elevates the risk of heart attack and stroke

An image dispalying the common painkiller

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has warned stating a common painkiller, diclofenac, raises the risk of heart attack and stroke among patients with serious underlying heart conditions. The most common painkiller drug Diclofenac is sold under colossal trade names such as Diclomax, Defenac, Diclofex, Dyloject, Econac, Enstar, Flamrase, Flamatak, Motifene, Rheumatac, Rhumalgan, Volsaid, and Voltarol. Reviews of Diclofenac and related medicines carried out during 2005, 2006 and 2012 have confirmed that NSAIDs class are associated with a small increased risk of arterial thromboembolic events (blood clots in the arteries) especially in those patients with underlying heart or circulatory conditions.

For all NSAIDs MHRA recommends that these medicines may be used at the lowest effective dose for the shortest period of time necessary to control symptoms.

MNT, 01 Jul 2013

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s